Recent Staff Announcements at Fox Chase Cancer Center


Get Permission

Philip A. Pancari, MD

Philip A. Pancari, MD

Philip A. Pancari, MD, has joined the Department of Hematology/Oncology at Fox Chase Cancer Center, providing additional physician support for the Fox Chase Cancer Center–Temple University Hospital Bone Marrow Transplant (BMT) Program.

“Having worked at Fox Chase for the past 3 years as a hematology/oncology fellow, I’ve enjoyed treating patients using the Center’s multidisciplinary approach,” Dr. Pancari said. “It’s been beneficial to me as a physician to complete a fellowship in this type of team environment, and I think it’s also been beneficial to patients. I’m honored to continue my work in the Temple Health System.”

Dr. Pancari is a licensed, board-certified physician. He earned his medical degree at Boston University School of Medicine. Dr. Pancari then worked as an internal medicine intern and later as a resident at Thomas Jefferson University Hospital in Philadelphia. In 2013, he became a hematology/oncology fellow at Temple University and Fox Chase Cancer Center.

Shuanzeng (Sam) Wei, MD, PhD

Shuanzeng (Sam) Wei, MD, PhD

Shuanzeng (Sam) Wei, MD, PhD, has joined the Department of Pathology at Fox Chase Cancer Center as an Assistant Professor, where he will specialize in surgical pathology and cytopathology.

“I’m truly humbled to be joining such a prestigious group of doctors and researchers at Fox Chase Cancer Center,” Dr. Wei said. “I look forward to working with the talented pathologists to advance the study of cancer diagnoses on the cellular level.”

Dr. Wei is a licensed, board-certified pathologist who earned his medical degree from North China University of Science and Technology in Tangshan, China, where he was then appointed as Instructor in the Department of Pathology. He earned his doctoral degree in pathology from Peking Union Medical College in Beijing, where he also completed 1-year surgical pathology residency training.

He later finished postdoctoral research fellowships in biologic chemistry at the University of California, Irvine, and in urology at Johns Hopkins University School of Medicine. Then he completed a combined anatomic pathology and clinical pathology residency, a surgical pathology mini-fellowship, and most recently, a fellowship in cytopathology—all at the Hospital of the University of Pennsylvania. ■



Advertisement

Advertisement



Advertisement